Filing Details

Accession Number:
0001209191-22-035277
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-06-09 06:00:17
Reporting Period:
2022-06-07
Accepted Time:
2022-06-09 06:00:17
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1828522 Effector Therapeutics Inc. EFTR () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1283307 T Stephen Worland C/O Effector Therapeutics, Inc.
142 North Cedros Avenue, Suite B
Solana Beach CA 92075
President And Chief Executive Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-06-07 20,000 $1.37 214,978 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 562,339 Indirect By Trust
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.34 to $1.39. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.